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Abstract. Breast conserving surgery allows complete
tumor resection while maintaining acceptable cosmesis
for patients. Safe and rapid intraoperative margin assess-
ment during the procedure is important to establish the
completeness of tumor excision and minimizes the need
for reoperation. Confocal laser endomicroscopy has dem-
onstrated promise for real-time intraoperative margin
assessment using acriflavine staining, but it is not
approved for routine in-human use. We describe a custom
high-speed line-scan confocal laser endomicroscopy
(LS-CLE) system at 660 nm that enables high-resolution
histomorphological imaging of breast tissue stained with
methylene-blue, an alternative fluorescent stain for local-
izing sentinel nodes during breast surgery. Preliminary im-
aging results on freshly excised human breast tissue
specimens are presented, demonstrating the potential of
methylene-blue aided rapid LS-CLE to determine the
oncological status of surgical margins in-vivo. © The
Authors. Published by SPIE under a Creative Commons Attribution 3.0
Unported License. Distribution or reproduction of this work in whole or in
part requires full attribution of the original publication, including its DOI.
[DOI: 10.1117/1.JBO.22.2.020501]
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Breast cancer is a major public health problem worldwide and
the second leading cause of cancer-related female deaths. In
2012, there were an estimated 464,000 new cases of female
breast cancer and 131,000 deaths in Europe alone.1 Breast con-
serving surgery (BCS), in the form of wide local excision with
glandular remodeling, is an attractive option for patients as it
allows complete tumor resection while maintaining acceptable
cosmesis and the oncological outcome is similar to a mastec-
tomy.2,3 However, on average, ∼20% to 30% of BCS patients
require one or more reoperative interventions, mainly due to
the presence of positive or close margins in postoperative his-
tological analysis of the resected tissue.4,5
For breast surgical procedures, conventional excision biopsy
followed by histology imaging is still required for comprehen-
sive assessment of margin status. While traditional histology
provides high diagnostic accuracy, it is labor-intensive and
slow, adding ∼20 to 30 min to the duration of the operation.6
One potential avenue for reducing reoperation rates following
BCS is the use of high-resolution intraoperative imaging to
determine if the radial margins are tumor-free during surgery.
Optical imaging techniques, including optical coherence tomog-
raphy,7 confocal reflectance microscopy,8 and nonlinear micros-
copy,9 are currently being investigated for in-vivo visualization
of breast morphology.
Probe-based confocal laser endomicroscopy (pCLE) is one
such emerging optical biopsy technique that is suitable for intra-
operative margin assessment as it can provide real-time imaging
of tissue structure with microscopic resolution. The method typ-
ically uses a flexible optical fiber bundle to relay light to and
from the tissue, and cellular features are made visible by exog-
enous staining prior to imaging. A preliminary study on 71
ex-vivo breast tissue samples imaged with the Cellvizio
pCLE system (Mauna Kea Technologies) demonstrated that
cancerous and normal tissue could be differentiated by histopa-
thologists with an accuracy of 94%.10 This study used topically
applied acriflavine, excited at 488 nm, which stains cell nuclei
and enables high contrast imaging of tissue morphology.
However, this is not currently an attractive option for in-vivo
imaging due to the lack of regulatory approval and suggested
risks of mutagenicity.11
To avoid these safety concerns, a subsequent in-vivo human
study used intravenous fluorescein as the contrast agent, a com-
pound that is well-established as being safe for in-vivo human
use12 and is commonly employed for other clinical applications
of pCLE.13,14However, since fluorescein staining is nonspecific,
it does not highlight tissue morphology as effectively, causing
difficulties in distinguishing between benign and malignant
lesions.12
For intraoperative margin assessment in routine clinical prac-
tice, it is desirable to use endomicroscopes with approved fluo-
rescent dyes, which are both safe for in-vivo human use and
provide sufficient contrast to discriminate between different tissue
morphologies. In this letter, we demonstrate that normal and can-
cerous breast tissue stained with methylene-blue, and excited at
660 nm, exhibits comparable morphological features to acrifla-
vine-stained tissue. Crucially, methylene blue is a US Food
and Drug Administration approved dye for the treatment of meth-
emoglobinemia and is an alternative to isosulphan blue for in-vivo
localization of nonpalpable lesions and sentinel lymph node map-
ping during breast surgeries.15–17 Topical methyelene blue has
also been demonstrated to image precancerous and neoplastic
lesions of central airways using a CLE system.18,19
Images were acquired ex-vivo using a custom high-speed
line-scan confocal laser endomicroscopy (LS-CLE) system
operating at 660 nm. The system configuration is illustrated
in Fig. 1(a). The system set-up is similar to a previously devel-
oped virtual slit LS-CLE at 488 nm but is adapted and optimized
for methylene-blue imaging. A full description of the system’s
operating principles can be found in Ref. 20. In brief, a cylin-
drical lens (f ¼ 50 mm) is used to create a focused line from a
100 mW, 660 nm laser (Vortran Stradus, 660). A galvomirror
(Thorlabs GVS001) sweeps the line across the proximal end
of the fiber bundle probe (Cellvizio Gastroflex UHD, Mauna
Kea Technologies) in a direction perpendicular to the line.
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The fiber bundle probe relays the line to the tissue via a distal
objective and returns collected fluorescence from all the points
along the line, which is then imaged onto a monochrome rolling-
shutter CMOS camera (Flea 3, FL3-U3-13S2M-CS). In this
design, the rolling shutter of the CMOS camera operates as a
virtual detector slit that rejects most of the out-of-focus light,
leading to optical sectioning at frame rates of up to 120 Hz.
To accommodate the 660-nm excitation wavelength, the
dichroic and emission filters from the system reported
previously20 were replaced with a Thorlabs-DMLP650R long-
pass dichroic mirror and a Semrock BLP01-664R-25 long-
pass edge filter, respectively.
The spatial resolution of the system was measured by back-
illuminating a 1951 USAF resolution target with a red LED;
Fig. 1(b) shows an image of group 7 of the target. For real-
time visualization, pixelation artifacts due to the fiber cores
were removed by convolution with a 2-D Gaussian filter
(σ ¼ 1.6 pixels, 1.4 μm on the proximal face of the bundle).
Figure 1(b) shows an image of the numeral “7” of the resolution
target before (top) and after (bottom) removal of pixelation arti-
facts. Figure 1(c) demonstrates the axial sectioning strength of
LS-CLE for detector slit-width of 4 μm (measured as described
in Ref. 20). For this study, a slit width of 4 μm was used to give
an axial resolution of ∼11 μm. While point-scanning pCLE
would probably be needed for intravenous fluorescein imaging
(see Ref. 20 for a discussion), our partially sectioning system is
sufficient for imaging tissue sites topically stained with methyl-
ene blue and provides the advantage of a much higher frame
rate. The high frame rate enables image mosaics to be assembled
more readily,21 which, as discussed in Ref. 10, is important for
allowing features to be identified with confidence.
A total of 15 freshly excised tissue samples were acquired
from five patients, who underwent breast surgery between
March and August, 2016, under an Imperial College tissue
bank license (Project R12047). Several small cut-outs, approx-
imately 10 × 10 mm in size, were taken from normal and dis-
eased sections (as subsequently confirmed by histology) and
imaged using the following protocol ∼30 to 45 min after
excision.
Methylene blue could be applied topically for in vivo imag-
ing, as demonstrated in Ref. 19. For this ex-vivo study, methyl-
ene blue solution (0.1% in saline; Sigma Aldrich, United
Kingdom) was applied topically to each cut-out for 30 s fol-
lowed by a gentle wash with PBS saline to remove excess
stain. The tip of the endomicroscope probe was gently applied
to the tissue surface. At the end of the imaging procedure, excess
methylene-blue dye was gently wiped off the surface of the tis-
sue, and the specimen was returned to histology for routine
analysis.
In postprocessing, a mosaicking algorithm was used to stitch
overlapping frames, producing a larger image more comparable
to histology slides. This algorithm, described fully in Ref. 21
and based on an established procedure,22 uses two-way fast nor-
malized cross-correlation (NCC) for pairwise image registration
and combines images using distance-weighted alpha-blending.
Mosaics were then stored digitally in a prospectively maintained
database. To assist with probe scanning during image acquisi-
tion, a real-time preview of the mosaics, using one-way NCC
and dead-leaf blending, was displayed to the operator.
The accuracy of normal/tumor identification using acrifla-
vine staining pCLE has already been established;10 so, the
main purpose of this pilot study was to determine whether
the 660-nm system could identify features following the tax-
onomy of pathologies developed in the previous study. A
total of 450 pCLE image mosaics (mean 30 per sample;
range 20 to 40) were generated from 15 specimens. Since we
have a limited number of tissue samples, we acquired many
more mosaics than necessary for detailed performance assess-
ment. Figure 2 provides representative LS-CLE image mosaics
of freshly excised normal, benign, and neoplastic human breast
specimens stained with methylene blue. The potential of the
approach to identify the microscopic tissue morphology relevant
to tumor identification is demonstrated by comparison of the
reconstructed mosaics with those from the previously generated
data bank generated using the Cellvizio pCLE with acriflavine
(0.02%) staining, and with conventional histology.10
Two features typifying normal breast tissue were identified:
adipose tissue and the presence of collagen fibres in the stroma.
As shown in Figs. 2(a) and 2(b), the fluorescence images obtained
from methylene-blue and acriflavine-stained adipose tissue are
similar: the well-defined and uniform nonfluorescent polygon
shape of the adipose tissue with hyperfluorescent borders can
clearly be observed in both cases. Nuclei, which may not always
be clearly visible, appear as sparsely populated bright spots on the
borders. In Figs. 2(d) and 2(e), the fibrous connective tissue
appears as hyperfluorescent bundles of elastic wavy fibres.
Figures 2(g) and 2(h) represent fibrocystic changes, where com-
pressed bright slit-like glandular spaces are surrounded by loose
fibrous stroma. In Figs. 2(j) and 2(k), stroma composed of
hyperfluoroscent spindle-shaped fibroblasts appear surrounded
by gray collagen fibers. Also, both the systems enable visualiza-
tion of distinctive neoplastic changes characterized by increased
cellularity in the stroma, as depicted in Figs. 2(m) and 2(n).
Fig. 1 (a) Schematic layout of high-speed LS-CLE system operating
at 660 nm. (b) Image of high-resolution USAF resolution target show-
ing group 7 elements 1-6 when back-illuminated with a red LED.
(c) Axial sectioning profile for the line-scanning system.
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The disorganized distribution of cell nuclei and the unclear tissue
architecture was clearly visible as large clusters of hyperfluorescent
spots. Similar features are observed in matched histology images of
acriflavine-stained tissue (c, f, i, l, and o). Furthermore, we com-
pared the signal-to-noise ratio (SNR) of the two sets of images,
obtained by the ratio of the mean intensity of a homogenous
stained area of 10 × 10 pixels of the tissue (signal) to the standard
deviation of an unstained region of 10 × 10 pixels (noise).
Averaged across 100 images, the SNR was (179 10) for the acri-
flavine-stained images and (170 13) for the methylene-blue
stained images. Therefore, despite the differences in stain, imaging
system and processing, the noise in the final processed images are
broadly comparable.
In summary, a high-speed 660-nm LS-CLE system has been
used with topical application of 0.1% methylene blue to dem-
onstrate rapid morphological assessment of ex-vivo breast
cancer tissues. Images and mosaics of normal and neoplastic
breast tissue, acquired with a lateral resolution of 2.2 μm at
120 Hz, showed distinctive morphological features. The methyl-
ene blue aided LS-CLE produced images with comparable con-
trast to point-scanning pCLE with acriflavine staining but with
the advantage of a higher frame rate and use of a safe and regu-
latory-approved (off-label) stain.
These current results suggest a clinical application for
methylene-blue aided LS-CLE in breast cavity scanning for
rapid decision-making during BCS, allowing oncological status
of resection margins to be determined intraoperatively. This
could allow the surgeon to accomplish more accurate and com-
plete surgical resections, thus reducing the reoperation rates and
improving outcomes. Further work will be required to confirm
that the quantitative accuracy when using methylene-blue stain-
ing is similar to that when using acriflavine and to establish
whether similar images can be obtained in-vivo.
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